Post Learning Implementation Plan (PLIP)

Pre-course

• Access to the Educo Training Portal
• Submit your needs analysis and objectives for training by completing a simple online form

Action Plan

• At the end of the training you will create an action plan to help you implement and develop your new skills and knowledge

Reinforcement Session

• Delivered 3 to 4 weeks after the training
• It is a 1 hour virtual session enabling the group to reinforce the key learnings from the training and cover subsequent questions and challenges

Introductory Module 1

FREE to Attend | Live & Recorded

Sign up

22 October 2025 | 60 mins | 1:00 PM UK

Introduction to Pharmacology

• Overview of pharmacology and its importance in drug development
• Key terminology and concepts in pharmacology
• The role of pharmacology in understanding drug action and therapeutic potential

Register For Module 1 | Free

There are limited spaces on module 1. If demand is high you may not be able to attend the live session, however you will be sent the recording. Priority is given to full registrations.

Day 1

24 November 2025 | 180 mins | 1:00 PM UK

Introduction to Pharmacology

• Overview of pharmacology and its importance in drug development
• Key terminology and concepts in pharmacology
• The role of pharmacology in understanding drug action and therapeutic potential

In Vitro Pharmacology

• Principles and techniques of in vitro pharmacology
• Common assays and models used to evaluate drug activity at the molecular and cellular levels
• Applications of in vitro pharmacology in drug discovery and early development

Day 2

25 November 2025 | 180 mins | 1:00 PM UK

Ex Vivo Pharmacology

• Understanding ex vivo pharmacology and its role in drug development
• Techniques for assessing drug effects on isolated tissues and organs
• Integrating ex vivo data with in vitro and in vivo findings

In Vivo Pharmacology

• Overview of in vivo pharmacology and its significance in preclinical development
• Animal models used in pharmacology research, including rodent and non-rodent species
• Designing and interpreting in vivo studies to assess efficacy, safety, and pharmacokinetics

Day 3

26 November 2025 | 180 mins | 1:00 PM UK

Preclinical Models, Translational Medicine and Regulatory Considerations

• Selection and validation of preclinical models for drug development
• Understanding the regulatory expectations for pharmacology data in IND submissions
• Strategies for ensuring data integrity and regulatory compliance in preclinical pharmacology

Pharmacology Data Maturity and Data Packages

• Building a comprehensive pharmacology data package for exploratory, preclinical, and clinical programs
• Criteria for data maturity at different stages of drug development
• Integrating pharmacology data into the overall development strategy and regulatory submissions

Day 4

27 November 2025 | 180 mins | 1:00 PM UK

Introduction to Clinical Pharmacology

• Basics of clinical pharmacology and its role in translating preclinical findings to humans
• Key concepts, including pharmacokinetics (PK), pharmacodynamics (PD), and dose-response relationships
• The importance of clinical pharmacology in designing and executing early-phase clinical trials

Case Studies and Practical Applications

• Real-world examples of how pharmacology data informs drug development decisions
• Lessons learned from successful and challenging pharmacology programs
• Emerging trends in pharmacology research and their impact on drug development

Gareth Willis is an experienced biopharmaceutical R&D professional, drug hunter and global project lead with 10+ years of leadership in project/program management, portfolio governance and scientific strategy. He has a successful record of progressing complex, multi-million-dollar drug development programs through internal and external initiatives. He has furthered his practical experience in both Europe and the US, in clinical, pharmaceutical, VC and academic environments facilitating the preclinical -> clinical transition of novel medicinal products. Relevant former roles and institutions include Principal Investigator/Lecturer (Harvard Medical School & Boston Children’s Hospital), Fellow and Project Lead (Vertex Pharmaceuticals), Global Project Lead (Boehringer-Ingelheim) and Asset and Scientific Evolution Lead (invoX Pharma).

In his current role(s), he leads a dynamic cross-functional global team that pushes scientific and drug development boundaries, developing novel medicinal products and drug-device combinations (modality and indication agnostic), to meet unmet patient needs worldwide. He has a wealth of experience in establishing agile governance frameworks to oversee a diverse clinical and preclinical portfolio. Notably, he has extensive experience in translational biomarker strategies, indication expansions (repurposing), and effective tech-transfer for up-scale bioprocessing of biologics.

Overseeing a global team, Gareth has a proven track record in increasing pipeline visibility and executing external collaborations. He has bridged the gap between preclinical -> clinical, implementing novel ‘first-4-patient’ initiatives, such as 5’R research frameworks, relevant clinical biomarker strategies and optimising human dose prediction models to enhance the probability of success of medicinal products.